Related Experiment Video
Updated: Jul 9, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency
S A Thompson1, J Calvin, S Hogg
1Department of Neurology, Addenbrooke's Hospital, Cambridge, UK.
Abstract:
Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder and highlights the importance of screening for plasma pristanic acid levels in patients with unexplained relapsing encephalopathies.
Related Concept Videos
Hepatic Encephalopathy
Alzheimer Disease ll: Pathophysiology
Inborn Errors of Metabolism
Rocky Mountain Spotted Fever
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
